BNN.DE Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (7 May 2024 @ 11:36):

Stats
Today's Volume	5 285.00
Average Volume	6 481.00
Market Cap	60.08M
EPS	€0 ( 2024-02-27 )
Next earnings date	( €0 ) 2024-05-28
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-7.24
ATR14	€0 (0.00%)

BRAIN Biotechnology Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

BRAIN Biotechnology Financials

Annual	2023
Revenue:	€55.34M
Gross Profit:	€30.12M (54.44 %)
EPS:	€-0.380

FY	2023
Revenue:	€55.34M
Gross Profit:	€30.12M (54.44 %)
EPS:	€-0.380

FY	2022
Revenue:	€49.51M
Gross Profit:	€27.45M (55.44 %)
EPS:	€-0.290

FY	2021
Revenue:	€38.39M
Gross Profit:	€21.57M (56.19 %)
EPS:	€-0.250

Financial Reports:

No articles found.

BRAIN Biotechnology

BRAIN Biotech AG researches, develops, produces, and markets enzymes, biocatalysts, microorganisms, and bioactive natural substances for chemical industries in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates in two segments, BioScience and BioIndustrial. It identifies and develops bioactive natural compounds, including sugar substitutes and taste modulators, and nature-based active ingredients for product development in the food, animal feed, skin care, cosmetics, and chemical industries. The company also identifies and develops optimized enzymes and biocatalysts for the production of food and beverages, and wound care preparations or lubricants, as well as for starch processing of bioethanol production; and microorganisms as the functional biomass for optimized industrial production processes, recycling of greenhouse gas CO2 as an industrial raw material, and extraction of precious and rare earth metals. It has strategic partnerships with AnalytiCon Discovery GmbH and Roquette to develop natural sweeteners and sweet taste enhancers. The company was formerly known as B.R.A.I.N. Biotechnology Research and Information Network AG and changed its name to BRAIN Biotech AG in April 2021. BRAIN Biotech AG was founded in 1993 and is headquartered in Zwingenberg, Germany.